BlossomHill Therapeutics, Inc. (BLSM)
$17.29-13.29%Close
SELL
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $503M
- Beta
- 0.00
- P/E (TTM)
- -1.83
- Shares short
- 137.6K
- Days to cover
- 1.0
- SI change
- +24.2%
- 1W
- -19.09%
- 1M
- -21.44%
- vs SPY 1W
- -21.04%
- vs SPY 1M
- -22.85%
Industry peers
FMP comparable companies · ranked by market cap
- RLAYSELLRelay Therapeutics, Inc.$4.1BRECOVERYQ 3$18.74-3.35%
- NRIXSELLNurix Therapeutics, Inc.$2.3BBEARQ 11$22.60-1.22%
- AGIOSELLAgios Pharmaceuticals, Inc.$1.9BRECOVERYQ 4$31.72+1.50%
- GLUESELLMonte Rosa Therapeutics, Inc.$834MCRISISQ 7$9.87-3.89%
- AVBPSELLArriVent BioPharma, Inc.$703MCRISISQ -8$15.09-46.98%
- FTHSELLFaeth Therapeutics, Inc.$693MCRISISQ -6$26.89-0.77%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 24
- VALUE
- 14
- GROWTH
- 45
- GARP
- 9
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC76.7%
REV YoY-
ROE127.8%
EPS YoY-
ROA-36.1%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-1.83
P/E FWD-
SECTOR PE20.26
INDUSTRY PE14.12
P/B5.72
P/FCF-
EV/EBITDA-9.23
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E28.49
ALTMAN Z-
CURR RATIO5.42
ND/EBITDA-
BETA0.00
